Treating Locally Advanced Head and Neck Malignant Tumor With Anlotinib and Chemoradiotherapy

NCT04507035 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: Anlotinib hydrochloride capsules

Sponsor

Sun Yat-sen University